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Lixia Rong1, Kun Ding2, Meizeng Zhang2 and Yunliang Guo1*Abstract
Objective: To observe the effects of neuregulin1β (NRG1β) on the level of phosphorylated ERK1/2 (p-ERK1/2), and
explore the therapeutic mechanism of NRG1β on the cognitive dysfunction in rats with chronic omethoate poisoning.
Methods: Rats with strong learning and memory ability, 50 in total, were selected by Y-electric maze test. Among
which, 15 rats were randomly selected into control group, and the rest 35 rats were used to establish experimental
cognitive impairment models by being injected with omethoate subcutaneously. The 30 cases of successful cognitive
impairment models were randomly divided into model group and treated group consisting of 15 rats, respectively.
Then rats in treated group were injected with NRG1β into their lateral ventricles, while rats in control and model groups
were given equal volume of PBS simultaneously. The cognitive capacity of rats was evaluated with Y-electric maze. The
morphology and ultrastructure of hippocampus were observed by hematoxylin eosin (HE) staining and transmission
electron microscopy (TEM) respectively. The expression of p-ERK1/2 was determined by immunohistochemical (IHC)
staining and Western blotting.
Results: Compared with rats in model group, the cognitive ability of rats with omethoate exposed (model and treated
groups) reduced significantly, along with the obvious damage of hippocampal neurons and the expression of p-ERK1/2
decreased significantly (P < 0.05). And after treatment with NRG1β, the cognitive activity of treated rats was improved
obviously, and the injury of hippocampal neurons was milder and the expression of p-ERK1/2 increased significantly
more than those in model rats (P < 0.05).
Conclusion: In chronic omethoate poisoning rats, NRG1β can promote the phosphorylation level of ERK1/2 in
hippocampal neurons, and play an important role in the improvement of cognitive function.
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As a kind of economical and efficient pesticides, organo-
phosphorus pesticides (OPs) have been widely applied
around the world. With strong toxicity, the remaining
OPs can be accumulated for a long time after entering
the body, and would be greatly harmful to human health
[1]. Epidemiological data indicated that long-term expos-
ure to low dose OPs would lead to cognitive dysfunction,
mainly shown as the decline of learning and memory
ability [1,2]. Up to now, no effective treatment has been* Correspondence: guoqdsd@163.com
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unless otherwise stated.found for the cognitive dysfunction caused by chronic
poisoning with OPs. Previous studies [3,4] showed that
chronic poisoning with OPs could cause the reduction
of muscarinic acetylcholine receptors(mAChRs) in brain,
as well as its affinity for acetylcholine(Ach), finally lead-
ing to the tolerance to Ach. As one of the most import-
ant neurotransmitters in the central nervous system,
Ach is widely distributed in brain, and involved in the
neuronal activity of hippocampus and cortex. It can
regulate the synaptic plasticity and plays an import-
ant role in the processes of learning and memory.
Rosenblum et al. [5] found that the realization of learning
and memory function which is mediated by acetylcholine
neurons depends on the activation of ERK1/2 signalinghis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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OPs poisoning rats, the learning and memory ability and
the phosphorylated activation level of ERK1/2 in brain
were reduced significantly [6]. So it was speculated that
the cognitive dysfunction caused by OPs might be related
with the blocking of ERK1/2 signal transduction pathway.
As a member of epidermal growth factor family, neure-
gulins (NRGs) can activate multiple signal transduc-
tion pathways (including ERK1/2 pathway) after binding
to its ErbB receptors, and display a number of roles in the
developing and mature nervous systems. Several lines of
evidence [7,8] suggest that in rats with cerebral ischemia-
reperfusion injury, NRG1β played an important role in
anti-apoptosis effect by regulating the expression of STAT3,
GFAP and AQP-4. Subsequently, some studies found
NRG1β could also inhibit inflammation and apoptosis in
brain of dementia rats [9,10], as well as prevent the dam-
age of long-term potentiation (LTP) in hippocampus and
regulate the synapse formation and plasticity [11]. There-
fore, in animals with chronic organophosphorus poison-
ing, the protective effects of NRG1β on hippocampal
neurons and its improvement on the cognitive impair-
ment can be expected, as well as it effects on the activa-
tion of ERK1/2.
Omethoate is one of the most frequently used organo-
phosphorus pesticides in China. It’s an structural analog
of dimethoate with strong toxicity. Due to its high toxicity,
frequent use and appearance, omethoate is of public con-
cern and on the list of Priority Monitoring Pesticides pub-
lished by the Ministry of Environmental Protection of the
People’s Republic of China. In this study, the authors
aimed at establishing chronic organophosphate poisoning
models by injecting omethoate subcutaneously, and ex-
ploring the possible mechanism of NRG1β improving cog-
nitive dysfunction by determining the phosphorylation
level of ERK1/2 (p-ERK1/2) in hippocampus.
Materials and methods
Animals
Total of 50 healthy adult male Wistar rats (weighting 230-
250 g, SPF grade) were provided by Experimental Animal
Center of Qingdao Drug Inspection Institute (SCXK (LU)
20120010). Animals were housed at the ambient temperature
of 21-25°C, with natural illumination and free access to food
and water for one week to adapt the environment. This ex-
periment was approved by the Ethics Committee of Qingdao
University Medical College (QUMC 2011-09). The local
legislation for ethics of experiment on animals and guide-
lines for the care and use of laboratory animals were
followed in all animal procedures.
Animal screening
After acclimatizating in Y-electric maze for 3 minutes,
each rat was placed in one arm of the Y-electric mazeand stimulated by electricity (60 V, 0.5 ~ 0.7 mA, 5 s de-
layed), at the same time one of the other two arms was
given light as a signal of safety, and the other arm with-
out light signal was dangerous with electrical current
flowing. If the rat ran directly to the safe area in 10 s, we
considered it as a correct response, otherwise, error re-
sponse. After the rat escaped into the safe area, the light
continued lasting for 30 seconds for the rat to consolidate
memories, then the light was turned off and the second
training started from the arm where the rat currently
stayed (that is the safe area of last training), and either
arm was given light signal. Carry on again and again thus
ten times every day for 7 days. And in the seventh day,
during the ten continuous trainings, the rats reacted cor-
rectly for at least 9 times (50 in total) were taken into the ex-
periment. 15 rats were selected randomly into control group,
and the rest 35 were used to establish chronic omethoate
poisoning cognitive impairment models.
Establishment of models
The 35 rats were subcutaneously injected with 5 mg/kg
(2 ml/kg) omethoate (Shandong Dacheng Pesticide Co.
Ltd., CAS No: 1113-02-6, purity: 40%) every day for 4 weeks;
and the 15 rats in control group (n = 15) were given equal
volume of normal saline simultaneously. After the expos-
ure for 4 weeks, the learning and memory abilities of rats
were tested by Y-electric maze for 10 times continuously.
If one rat reacted correctly less than 6 out of 10 times, we
considered the rat had cognitive impairment. The 30 suc-
cessful model rats of cognitive impairment were ran-
domly divided into model group (n = 15) and treated
group (n = 15).
Interventions
NRG1β (Cat. 100-03, Pepro. Tech. Co. Ltd. USA) was
dissolved and diluted with 0.1 mol/L PBS buffer solution
to 1 g/L (1 μg/μl). On the first and the eighth day after
modeled successfully, each rat in treated group was
injected with 5 μl of NRG1β through the left and the
right lateral ventricle (AP = 0.8 mm, ML/MR = 1.1 mm,
DV = 3.6 mm) respectively. And the rats in control
group and model group were given equal volume of PBS
buffer solution simultaneously. During the intervention
period, 2 rats in model group died. After exposed to
omethoate for 4 weeks, the immunity of exposed rats
was damaged seriously. The two exposed rats with no
treatment may be too weak to survey.
Memory reappearance test
Seven days later after the second administration of NRG1β,
all rats (43 in total, with 15 in both control group and
treated group, 13 in model group) were tested by Y-electric
maze for 10 times continuously.
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Paraffin section
Five rats in control group, 5 in treated group and 4 in
model group were randomly selected and anesthetized
with 10% chloral hydrate (3 ml/kg) intraperitoneal injection.
Then 200 ml normal saline and 200 ml 4% paraformalde-
hyde solution were perfused into the heart successively.
After that, the brain slice from 1 mm to 6 mm behind optic
chiasm was cut down and fixed in 4% paraformaldehyde
solution for 24 hours. Then the brain slices were dehy-
drated with graded series of ethanol, cleared with xylene
and embedded in paraffin in turn. Then the embedded tis-
sue was cut into sections of 5 μm thickness by a microtome
and adhered to the glass slices processed with poly-lysine
and stored at 4°C.
Ultrathin sections
Five rats in control group, 5 in treated group and 4 in
model group were randomly selected and anesthetized
with 10% chloral hydrate. Then the whole brain was
taken out, and bilateral hippocampi were stripped out.
Small amount of fresh tissue was cut from bilateral
hippocampi into some small pieces of about 1 mm ×
1 mm× 1 mm, and fixed in 2.5% glutaraldehyde for
24 hours. And then followed with 0.1 mol/L phosphate
buffer rinsed for 15 min × 3 times; fixed in 1% osmium
tetroxide for 2 hours, 0.1 mol/L phosphate buffer rinsed
for 15 min × 3 times, and then dehydrated with gradient
of acetone, embedded in Epon812 epoxy resin. Finally,
the embedded blocks were cut by the ultramicrotome
(Leica EM UC6, Germany) into ultrathin sections of
50 nm thickness which were placed on the nets prepared
with polyvinyl formal and stored at 4°C.
Protein extraction
Five rats were randomly selected from each group and
anesthetized with 10% chloral hydrate. And the whole
brain was taken out with bilateral hippocampi stripped
out on the ice. Then 100 mg hippocampus tissue was
placed into a 1.5 ml EP tube with a right amount of cell
lysis buffer (1 ml lysis buffer +10 μl PMSF, No. P0013B,
Beyotime Institute of Biotechnology). Then the tissue was
grinded fully and homogenized by ultrasonic and placed
on ice for one hour. Then the homogenate was centri-
fuged with 12000 rpm for 15 minutes at 4°C (Eppendorf
5417R, Germany). The supernate was collected to deter-
mine the concentration of protein by BCA Protein Assay
Kit (No. P0010, Beyotime Institute of Biotechnology), and
finally saved at -80°C.
Detection indexes
Hematoxylin-eosin (HE) staining
The paraffin sections were conventionally dewaxed and
rehydrated, followed with staining in hematoxylin for5 minutes, color separation with 1% hydrochloric acid
alcohol for 5 seconds, and staining in eosin for 2 minutes.
After that the paraffin sections were dehydrated by
graded series of ethanol, cleared by xylene, and finally
sealed with neutral gum. The structure of hippocam-
pus was observed under microscope (Leica DMI4000B,
Germany) at 400 times magnification. Four non-
overlapping horizons were randomly selected from
each slice for observation. The denatured cell index
(DCI = the number of denatured cells/the number of
total cells) was analyzed to evaluate the injury sever-
ity of hippocampus.
Transmission electron microscopy (TEM)
The 3% uranyl acetate-alcohol saturated solution (pH= 3.5)
and 6% lead citrate dye liquor (pH = 12) were prepared in
advance. A drop of 3% uranyl acetate-alcohol saturated so-
lution was dripped in a petri dish with clean wax-scale,
then covered by the nets with ultrathin sections which
contacted with the dye liquor to stain for 30 min, rinsed
with double-distilled water for 10 min × 3 times, sucked
up the water, covered with the 6% lead citrate dye liquor
which was dripped in another dish with clean wax-scale,
and the sections were contacted with the dye liquor to
stain for 5 min, rinsed with non-carbon dioxide double-
distilled water for 10 min × 3 times, blotted up water and
dried at room temperature. The ultrastructure of neurons
was observed under the transmission electron microscope
(JEM-1200EX, Japan).
Immunohistochemical (IHC) staining
Rabbit anti-rat p-ERK1/2 antibody and Rabbit anti-rat
ERK1/2 antibody were provided by Cell signaling tech-
nology Co. Ltd. PV-6001 immunohistochemisty kit and
DAB chromogenic solution were provided by Beijing
Golden Bridge Biotech. Co. Ltd. The paraffin sections
were conventionally dewaxed and rehydrated, and oper-
ated according to the specification of PV-6001 kit, col-
ored by DAB and re-dyed with hematoxylin. Finally the
paraffin sections were conventionally dehydrated by graded
series of ethanol, cleared by xylene, and sealed with neutral
gum. The positive cells showed brown granules in cyto-
plasm under light microscope. Four non-overlapping
horizons were selected randomly from each slice under
microscope at 400 times magnification. And LEICA Qwin
image-processing system was applied to analyze the mean
optical density (OD) of each horizon.
Western blotting
The objective proteins p-ERK1/2 (44, 42 kD), ERK1/2
(44, 42 kD) and β-action (42KD) were separated by so-
dium dodecyl sulfate polyacrylamide gel electrophor-
esis (5% concentrated gel on 80 V and 10% separating
gel on 120 V successively) and transferred onto the








Control group 15 9.60 ± 0.51 8.60 ± 0.83 8.93 ± 0.70
Modeled group 13 9.46 ± 0.52 4.31 ± 0.85* 4.23 ± 0.93*
Treatment group 15 9.53 ± 0.52 4.27 ± 0.80* 6.67 ± 0.90*#
*Compared with control group, P < 0.05; #Compared with modeled
group, P < 0.05.
Table 2 The analysis of denatured cell index (DCI) in HE
staining
Group n DCI
Control group 5 0.099 ± 0.019
Modeled group 4 0.236 ± 0.040*
Treatment group 5 0.158 ± 0.020*#
*Compared with control group, P < 0.05; #Compared with model group, P < 0.05.
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360 mA). Then the PVDF membrane was blocked in 5%
skimmed milk solution for 2 h at room temperature. After
that the PVDF membrane was incubated with p-ERK1/2
primary antibody (1:2000, CST, #4370) at 4°C overnight
and horseradish-peroxidase tagged goat anti-rabbit sec-
ondary antibody (1:10000, Abcam, ab136817) for 1 h at
room temperature successively. After each step, the PVDF
membrane must be rinsed sufficiently to avoid nonspecific
coloration. The gel film images was developed in A-B
mixed developing agent and scanned with Biospectrum
810 Imaging System. Then the PVDF membrane was dealt
with stripping buffer to remove the antibodies. After that
the membrane was blocked with skimmed milk solution
again, then re-incubated with ERK1/2 primary antibody
(1:1000, CST, #9102) or β-actin primary antibody (1:200,
Wuhan Boster Biological Co. Ltd., BA2305), and second-
ary antibody. Finally the images of ERK1/2 and β-actin
were developed. And the gray value of all protein bands
were measured and analysed with the Quantity one soft-
ware (Bio-Rad, USA). The relative gray value of protein was
calculated by the ratio of p-ERK1/2 or ERK1/2 gray value
to β-actin gray value.
Statistical analysis
SPSS 17.0 software was applied for the statistical ana-
lysis. The data was expressed as mean ± standard error
x  sð Þ . The analysis of variance and t-test were applied
for the two-group comparison.Figure 1 The morphological structure of hippocampus, HE × 400. A: C
pointed by black arrow). Hippocampal neurons in control rats were arrange
were loosely arranged,with cytoplasm condensed and nucleus pycnosis. In
than that in model rats.Results
Test of memory reappearance ability
The correct reaction times of poisoning rats (model
group and treated group) reduced significantly than that
in control rats (t = 15.24, 7.69, P < 0.05), but the correct
times in treated rats were obviously more than that in
rats of model group (t = 7.05, P < 0.05). Compared with
model rats, the learning and memory abilities of rats in
treated group were improved (Table 1).
HE staining
The structure of hippocampal neurons in control rats was
normal, and cells arranged in alignment, stained into shal-
low blue purple, and nucleolus obviously; In model group,
there was a certain degree of damage in hippocampal with
neurons loosely arranged, neuron shrinker, cytoplasm
condensed, nucleus pycnosis, and cells dyed darkness. In
treated group, with neurons arranged closer, the damage
of hippocampal neurons was slighter than that in rats of
model group, and the number of denatured cells was also
less than that in model group (Figure 1).
The analysis of denatured cell index (DCI): the DCI of
hippocampus in poisoning rats (model group and treated
group) was higher than that in control rats (t = 12.46,
9.38, P < 0.05); and the DCI of hippocampus in treated
rats was obviously lower than that in rats of model
group (t = 7.03, P < 0.05) (Table 2).
Ultrastructure of hippocampus
In control group, the structure of neurons was regular
with distinct outline and cytoplasm, and the chromatinontrol group, B: Modeled group, C: Treated group (Denatured cell was
d in alignment with nucleolus obviously; In model group, neurons
treated group, with neurons arranged closer, the damage was slighter
Figure 2 Ultrastructure of neurons in hippocampus, TEM × 5000 (up) and × 20000 (down). 1: Control group, 2: Modeled group, 3: Treated
group; Nm: Nuclear membrane, Ch: chromatin, Mi: Mitochondria, Go: Golgi apparatus, Vc: vacuoles caused by the dissolution of cytoplasm,
Ly: Lysosome. In control group, neurons had distinct outline and cytoplasm with uniform chromatin; while the morphology of neurons in model
group were irregular with uneven distribution of chromatin and dissolved cytoplasm vacuoles; the damage of neurons in treated group was
milder than that in model group, and only some slightly gathered chromatin and a small amount of dissolved cytoplasm can be found.
Figure 3 The expressions of p-ERK1/2 and ERK1/2 in hippocampus, IHC Staining × 400. A: Control group, B: Modeled group, C: Treated
group; 1: p-ERK1/2, 2: ERK1/2 (Positive cells were pointed by black arrow). In control group, a large amount of p-ERK1/2 positive cells stained as
brownish yellow could be observed. Compared with control group, neurons in model group were stained lightly and the number of p-ERK1/2
positive cells reduced significantly. In treated group, the number of p-ERK1/2 positive cells was more than that in model group. A large amount
of ERK1/2 positive cells can be observed in each group with no significant difference.
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Table 3 Optical density of p-ERK1/2 and ERK1/2 IHC
Staining in hippocampus
Group n p-ERK1/2 ERK1/2
Control group 5 59.38 ± 10.86 96.56 ± 12.76
Model group 4 27.82 ± 12.42* 93.60 ± 13.01
Treatment group 5 47.03 ± 11.69*# 100.57 ± 14.48
*Compared with control group, P < 0.05; #Compared with modeled
group, P < 0.05.
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was irregular with uneven distribution of chromatin, and
the vacuoles caused by the dissolution of cytoplasm can
also be observed; the damage of neurons in treated group
was milder than that in model group, and only some
slightly gathered chromatin and a small amount of dis-
solved cytoplasm can be found (Figure 2).Immunohistochemical (IHC) staining
In control group, hippocampal neurons were arranged in
neat rows, and a large amount of p-ERK1/2 positive cells
stained as brownish yellow could be observed under
microscope. Compared with control group, hippocampal
neurons in model group were arranged loosely and clut-
ter with lighter staining. The number of p-ERK1/2 posi-
tive cells in model group reduced significantly, and the
analysis of optical density (OD) showed that there was
significant difference between model and control groups
(t = 8.13, P < 0.05). In treated group, the number of p-
ERK1/2 positive cells was more than that in model
group, and analysis of OD showed a significant differ-
ence (t = 4.76, P < 0.05). Immunohistochemical staining
of ERK1/2 showed that there were a large amount of
ERK1/2 positive cells in each group, and the analysis of
mean OD showed no significant difference (t = 0.69-1.50,
P > 0.05) (Figure 3, Table 3).Figure 4 The expressions of p-ERK1/2 and ERK1/2 in hippocampus. A
significant difference in the expression of total ERK1/2 in hippocampus am
p-ERK1/2 in model and treated groups decreased significantly compared w
of p-ERK1/2 in treated group increased significantly.Western blotting
There was no significant difference in the expression of
total ERK1/2 in hippocampus among control, model and
treated group rats (t = 1.56, 0.97, P > 0.05), while the ex-
pression of p-ERK1/2 in model and treated groups de-
creased significantly and the gray value showed significant
difference (t = 9.49, 6.97, P < 0.05) compared with control
group. And in compare with model group, the expression
of p-ERK1/2 in treated group increased significantly, and
the analysis of gray value showed the difference was statis-
tically significant (t = 3.65, P < 0.05) (Figure 4, Table 4).
Discussion
The ERK signaling cascade is a central MAPK pathway
that plays a role in the regulation of various cellular pro-
cesses such as proliferation, differentiation, survival and mi-
gration [12,13]. The ERK pathway also has profound effects
on the regulation of apoptosis by the post-translational
phosphorylation of apoptotic regulatory molecules includ-
ing Bad, caspase 9 and Bcl-2 [14,15]. The protective effect
of ERK on neurons may also be related to the reduction of
some inflammatory factors. In the brains of aged rats, the
decline of activated ERK is often accompanied by the in-
crease of IL-1β. In addition, the reduction of ERK can cause
the decline of some neurotrophic factors, such as BDNF
and NGF. In brief, NRG1β plays a role in neuroprotective
effect by activating ERK1/2.
Besides, the abilities of learning and memory are also
related to the activation of ERK1/2. The function of
acetylcholine neurons about learning and memory de-
pends on the activation of ERK1/2 signaling pathway.
After acetylcholine binds with mAChRs, ERK1/2 path-
way can be activated, thus regulating the ability of learning
and memory [13]. After binding with cholinergic neuro-
transmitter, the activated receptor can activate G protein
specifically and promote the Gα subunit with GDP-bound
converting to GTP-bound. Then the affinity of Gα and
Gβγ subunits decreases, which furtherly causes the: Control group, B: Modeled group, C: Treated group. There was no
ong control, model and treated group rats, while the expression of
ith control group. And in compare with model group, the expression
Table 4 The relative gray value of p-ERK1/2 and ERK1/2
in hippocampus (%)
Group n p-ERK/actin ERK/actin
Control group 5 22.5 ± 2.5 42.9 ± 2.8
Model group 5 9.4 ± 1.8* 40.3 ± 2.4
Treatment group 5 13.2 ± 1.6*# 40.0 ± 5.9
*Compared with control group, P < 0.05; #Compared with modeled
group, P < 0.05.
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unit and Gβγ subunit can activate some molecules, such
as PKC, PI3K or Src, to activate ERK1/2 signaling
pathway.
The activation of ERK1/2 signaling pathway is essential
for various forms of synaptic plasticity. As an important
form of synaptic plasticity, long-term potentiation (LTP)
has been an important cellular model for the study of
learning and memory. LTP in hippocampus is believed
to be an important basis for learning and memory func-
tions [16]. In 1997, when English and Sweat [17] used
PD098059 to block the activation of ERK1/2, they found
the induction of LTP in hippocampus was inhibited sig-
nificantly, which confirmed the important role of ERK1/
2 in the induction of LTP. After that, more and more
studies confirmed that ERK1/2 signaling pathway played
an important role in the formation of LTP and the pro-
cesses of learning and memory [18-26]. The activation of
ERK1/2 could in turn affect the activation of some nu-
clear transcription factors which were related to synaptic
plasticity and the synthesis of related functional protein,
thus inducing the formation of LTP. For example, acti-
vated ERK1/2 could phosphorylate the Ser133 site of
cAMP response element-binding protein (CREB), thus
leading to the activation of CREB and the transcription
of cAMP response element (CRE)-related genes, finally in-
ducing the formation of LTP [27]. As an important nuclear
transcription factor, CREB was a necessary regulatory mol-
ecule in the formation of long-term memory. The activa-
tion of CREB played an important role in the maintenance
of late LTP in hippocampus, and was involved in the
process of learning and the consolidation of memory [28],
and the inhibition of CREB in hippocampus could cause
spatial memory impairment of rats [29].
In this study, after the exposure to omethoate for
4 weeks, the results of Y-electric maze showed that the
cognitive capacity of model rats declined significantly
compared with that of control rats. Under light micro-
scope, the hippocampal neurons of model rats arranged
loosely and clutter with cytoplasm condensed and nucleus
pycnosis; under electric microscope, the morphology of
hippocampal neurons was irregular with uneven distri-
bution of chromatin, and the phenomenon of apoptosis,
vacuolization and necrosis could also be observed. Compared
with model group, the learning and memory abilities ofrats in treated group were improved with milder damage
of hippocampus, which indicating that NRG1β played a
neuroprotective effect against the hippocampus injury and
could improve the cognitive ability of rats with omethoate
poisoning. The results of IHC staining and western blot
showed that the phosphorylated activation level of ERK1/
2 declined significantly in the hippocampus of poisoning
rats, but the activation level of ERK1/2 in rats with
NRG1β treated was obviously higher than that in rats of
model group. This indicated that ERK1/2 signal transduc-
tion pathway was involved in the cognitive impairment
caused by chronic omethoate poisoning, and NRG1β
played a neuroprotective effect by activating the ERK1/2
signal pathway, so as to improve the cognitive function of
rats. In future, we will furtherly explore the optimum
dose of NRG1β on improving the cognitive impairment
of rats caused by chronic omethoate poisoning and the
therapeutic effect of NRG1β in other kinds of cognitive
impairment.
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